Divi's Laboratories shines despite reporting 29% fall in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Divi's Laboratories is currently trading at Rs. 3514.80, up by 164.90 points or 4.92% from its previous closing of Rs. 3349.90 on the BSE.
The scrip opened at Rs. 3350.10 and has touched a high and low of Rs. 3528.20 and Rs. 3300.00 respectively. So far 22192 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 3949.00 on 08-Aug-2023 and a 52 week low of Rs. 2730.00 on 14-Mar-2023.
Last one week high and low of the scrip stood at Rs. 3528.20 and Rs. 3300.00 respectively. The current market cap of the company is Rs. 90751.76 crore.
The promoters holding in the company stood at 51.93%, while Institutions and Non-Institutions held 36.34% and 11.73% respectively.
The company has reported 29.77% fall in its net profit at Rs 342 crore for Q2FY24 as compared to Rs 487 crore for the same quarter in the previous year. However, total income of the company increased by 2.68% at Rs 1953 crore for Q2FY24 as compared Rs 1902 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 29.41% fall in its net profit at Rs 348 crore for the quarter under review as compared to Rs 493 crore for the same quarter in the previous year. However, total income of the company increased by 3.10% at Rs 1995 crore for Q2FY24 as compared Rs 1935 crore for the corresponding quarter previous year.
